Abstract-The role of vascular smooth muscle inward rectifier K ϩ (K IR ) channels in the mechanisms underlying vasodilation is still unclear. The hypothesis that K IR channels are involved in sodium nitroprusside (SNP)-induced dilation of rat-tail small arteries was tested. SNP relaxed tail small arteries with an EC 50 of 2.6ϫ10Ϫ8 mol/L. Endothelium removal did not attenuate this effect. Vessel pretreatment with hydroxocobalamin, a nitric oxide (NO) scavenger, but not with rhodanese and sodium thiosulfate, inactivators of cyanide (CN), abolished the SNP effect. Vessel pretreatment with 10 Ϫ5 mol/L Ba 2ϩ , a specific blocker of K IR channels at micromolar concentrations, reduced the SNP effect. Low concentrations of K ϩ dilated the vessels; this effect was attenuated largely after pretreatment with 3ϫ10 Ϫ5 mol/L Ba 2ϩ . In freshly isolated smooth muscle cells, a barium-sensitive current was observed at potentials negative to the potassium equilibrium potential. Application of 10 Ϫ4 mol/L SNP increased the barium-sensitive current 1.79Ϯ0.23-fold at Ϫ100 mV and hyperpolarized the membrane potential by 8.6Ϯ0.5 mV. In tissue from freshly dissected vessels, transcripts for K IR 2.1 and 2.2, but not for K IR 2.3 and 2.4, were found. However, only K IR 2.1 antibodies immunostained the tunica media of the vessel. These data suggest that vascular smooth muscle K IR 2.1 channels are involved in the SNP-induced dilation of rat-tail small arteries.
The hypothesis that cAMP-dependent protein kinase (protein kinase A; PKA) is in an active state in small arteries possessing a myogenic tone was investigated in pressurized rat tail small arteries. At a pressure of 80 mmHg, these vessels constricted to 71.6 ± 1.0% ( n = 32) of the diameter of the fully relaxed state. The PKA inhibitors Rp-8-(4-chlorophenylthio)-adenosine 3′,5′-cyclic monophosphothioate (Rp-CPT-cAMPS) and N-(2-{[3-(4-bromophenyl)-2-propenyl]amino}-ethyl)-5-isoquinolinesulfonamide HCl (H-89) constricted these vessels dose dependently. For example, 300 μM Rp-CPT-cAMPS and 9 μM H-89 reduced vessel diameter by 11.0 ± 1.2% ( n = 8) and 14.3 ± 3.6% ( n = 5), respectively. The cGMP-dependent protein kinase (protein kinase G; PKG) inhibitor Rp-8-bromo-β-phenyl-1, N 2-etheno-guanosine 3′,5′-cyclic monophosphothioate (Rp-8-Br-PET-cGMPS) did not alter vessel diameter up to a concentration of 10 μM. Neither endothelium removal nor inhibition of neural transmission affected the action of Rp-CPT-cAMPS. The effect of 300 μM Rp-CPT-cAMPS was reduced by 82% after pretreatment of the vessel with 100 nM iberiotoxin, a blocker of calcium-activated potassium (KCa) channels. However, the effect of 300 μM Rp-CPT-cAMPS was not altered after pretreatment with 1 mM 4-aminopyridine, a blocker of delayed rectifier potassium channels, or 10 μM ryanodine, a blocker of ryanodine receptor-generated calcium sparks. In inside-out patch-clamp experiments on cells isolated from rat tail small arteries, 10 U/ml of the catalytic subunit of PKA together with 100 μM MgATP increased KCa channel activity 30.1 ± 9.8-fold ( n = 9). Additionally, neither inhibition of PKA or PKG nor moderate activation of PKA or PKG altered the vessel response to a pressure step from 80 to 120 mmHg. These results suggest that in rat tail small arteries possessing a myogenic tone 1) PKA is in an active state modulating the level of the myogenic tone, and 2) KCa channels mediate, at least partly, this effect of PKA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.